Back to Search Start Over

Association of Interleukin-17A rs2275913 Polymorphism with Recurrent Miscarriage: A Systematic Review and Meta-Analysis Study.

Authors :
Keshavarz Motamed A
Zarei ZH
Mirfakhraee H
Shariatinia F
Akbari M
Ziagham S
Igder S
Zarei N
Source :
International journal of fertility & sterility [Int J Fertil Steril] 2023 Nov 01; Vol. 18 (1), pp. 7-11. Date of Electronic Publication: 2023 Nov 01.
Publication Year :
2023

Abstract

Recurrent miscarriage (RM) is a condition defined as having three or more consecutive pregnancy losses before the 20 weeks of pregnancy. The present study was undertaken to investigate association of Interleukin-17A (IL-17A) rs2275913 polymorphism with RM. To this end, we searched the international databases (Web of Science, PubMed, Embase, and Scopus) and extracted studies investigating the association of IL-17A rs2275913 polymorphism with RM using the appropriate keywords. The collected data were analyzed with the random-effects model and STATA (version 14). A total of five studies met the eligibility criteria, and total sample size was 998 subjects. Mean age of the cases and controls were 31.41 ± 4.16 and 30.56 ± 3.5 years, respectively. Our results disclosed a significant relationship of the IL-17A rs2275913 AA genotype [odds ratio (OR)=1.68; 95% confidence interval (CI)=1.16- 2.43; I2=19; P=0.294) with RM. There was no statistically significant correlation between IL-17A rs2275913 GG genotype (OR=1.04; 95% CI=0.64-1.7; I <superscript>2</superscript> =59.5; P=0.042) and GA genotype (OR=0.85; 95% CI=0.65-1.1 <superscript>2</superscript> ; I <superscript>2</superscript> =19.1; P=0.293) with RM. Our findings revealed that the IL-17A rs2275913 polymorphism is associated with RM, and the AA genotype of this polymorphism increased possibility of being involved in RM.

Details

Language :
English
ISSN :
2008-076X
Volume :
18
Issue :
1
Database :
MEDLINE
Journal :
International journal of fertility & sterility
Accession number :
38041453
Full Text :
https://doi.org/10.22074/ijfs.2023.546127.1248